Infectious Disease · Mycobacterial Infections
The facts most likely to be tested
Press 1–5 to rate · ↑↓ to navigate
Primary pulmonary tuberculosis typically presents with a Ghon focus in the subpleural mid-lung zone (lower upper lobes / upper lower lobes) and ipsilateral hilar lymphadenopathy, collectively known as the Ghon complex.
Reactivation tuberculosis classically manifests as cavitary lesions in the apical/posterior segments of the upper lobes due to high oxygen tension.
The gold standard for diagnosis is sputum culture on Lowenstein-Jensen agar, though NAAT (nucleic acid amplification test) is the preferred initial rapid diagnostic tool.
Extrapulmonary tuberculosis most commonly involves the spine, known as Pott disease, which presents with vertebral body destruction and psoas abscesses.
The standard initial treatment regimen for active tuberculosis is the RIPE therapy consisting of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol for two months followed by a continuation phase.
Isoniazid therapy requires concurrent pyridoxine (Vitamin B6) supplementation to prevent peripheral neuropathy and sideroblastic anemia.
Rifampin characteristically causes orange-red discoloration of body fluids, while Ethambutol is associated with optic neuritis and red-green color blindness.
Vignette unlocked
A 34-year-old immigrant from Southeast Asia presents with a 3-month history of chronic productive cough, night sweats, and a 10-lb unintentional weight loss. Physical examination reveals dullness to percussion and bronchial breath sounds at the right lung apex. A chest X-ray demonstrates a cavitary lesion in the right upper lobe. Sputum acid-fast bacilli smear is positive.
What is the most appropriate initial pharmacologic management for this patient?
Rifampin, Isoniazid, Pyrazinamide, and Ethambutol
The patient's presentation of chronic constitutional symptoms and apical cavitary lesions is classic for reactivation tuberculosis, which requires the standard 4-drug RIPE regimen.
Full handout
High yield triage
Etiology / Epidemiology
Caused by Mycobacterium tuberculosis; high risk in immigrants, HIV+, and crowded living conditions.
Clinical Manifestations
Chronic night sweats, hemoptysis, and apical cavitary lesions on imaging.
Diagnosis
Sputum acid-fast bacilli (AFB) smear/culture is the gold standard; IGRA or TST for latent screening.
Treatment
RIPE therapy (Rifampin, Isoniazid, Pyrazinamide, Ethambutol) for 2 months, then RI for 4 months.
Prognosis
High cure rate with adherence; multidrug-resistant TB (MDR-TB) requires prolonged, complex regimens.
Full handout
Epidemiology & Etiology
Transmitted via airborne droplets. Primary risk factors include HIV infection, substance abuse, and recent travel to endemic regions.
Pertinent Anatomy
Predilection for the pulmonary apices due to high oxygen tension. Extrapulmonary sites include the spine (Pott disease) and cervical lymph nodes (scrofula).
Pathophysiology
Inhaled bacilli are phagocytosed by alveolar macrophages, forming a Ghon focus. Granuloma formation leads to caseating necrosis; reactivation occurs when host immunity wanes.
Clinical Manifestations
Classic presentation includes fever, weight loss, and night sweats. Hemoptysis indicates advanced cavitary disease. Physical exam may reveal amphoric breath sounds over cavities.
Diagnosis
Sputum culture is the gold standard. TST (PPD) is positive at ≥5mm in HIV/immunosuppressed, ≥10mm in high-risk groups, and ≥15mm in low-risk individuals.
Treatment
Initiate RIPE therapy. Isoniazid requires pyridoxine (B6) to prevent peripheral neuropathy. Ethambutol causes optic neuritis; Pyrazinamide is associated with hyperuricemia.
Prognosis
Treatment success requires directly observed therapy (DOT) to prevent resistance. Liver function tests must be monitored due to the hepatotoxicity of R, I, and P.
Differential Diagnosis
Lung Cancer: weight loss without fever/night sweats
Histoplasmosis: exposure to bird/bat droppings
Sarcoidosis: bilateral hilar adenopathy without caseation
Pneumoconiosis: occupational dust exposure history
Lung Abscess: foul-smelling sputum and aspiration risk